Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Want more ideas
Minister Rists estimate of 100 million per year at full rollout implies a weighted average annual cost per treated patient of approximately 2,000 to 2,400 consistent with the maintenance-dose pricing of 195 per month
This lower dose is not intended to provide full glycaemic control but rather to allow the body to adjust to the medication and minimise gastrointestinal side effects
Also, one of the biggest challenges is that miRNAs can induce the off-target silencing since miRNAs are designed to target multiple pathways via imperfect matching with 3UTRs (van Dongen et al., 2008)
Thanks We thank all the participants, investigators, and trial-site staff from Medical Co
Solution: Ensure the needle is properly attached to the syringe and that it is the correct size
US$ 21.00
US$ 28.73
US$ 23.02
US$ 21.71
US$ 27.71
US$ 21.41
US$ 24.78
US$ 25.86
US$ 21.49
US$ 28.50
